Thiopurine S-methyltransferase pharmacogenetics: functional characterization of a novel rapidly degraded variant allozyme.

Biochemical Pharmacology
Qiping FengRichard M Weinshilboum

Abstract

A novel human thiopurine S-methyltransferase (TPMT) variant allele, (319 T>G, 107Tyr>Asp, *27), was identified in a Thai renal transplantation recipient with reduced erythrocyte TPMT activity. The TPMT*27 variant allozyme showed a striking decrease in both immunoreactive protein level and enzyme activity after transient expression in a mammalian cell line. We set out to explore the mechanism(s) responsible for decreased expression of this novel variant of an important drug-metabolizing enzyme. We observed accelerated degradation of TPMT*27 protein in a rabbit reticulocyte lysate. TPMT*27 degradation was slowed by proteasome inhibition and involved chaperone proteins-similar to observations with regard to the degradation of the common TPMT*3A variant allozyme. TPMT*27 aggresome formation was also observed in transfected mammalian cells after proteasome inhibition. Inhibition of autophagy also decreased TPMT*27 degradation. Finally, structural analysis and molecular dynamics simulation indicated that TPMT*27 was less stable than was the wild type TPMT allozyme. In summary, TPMT*27 serves to illustrate the potential importance of protein degradation - both proteasome and autophagy-mediated degradation - for the pharmacogenetic eff...Continue Reading

References

May 2, 1978·Clinica Chimica Acta; International Journal of Clinical Chemistry·R M WeinshilboumP A Pazmiño
Mar 1, 1982·Proceedings of the National Academy of Sciences of the United States of America·P O Seglen, P B Gordon
May 7, 2002·The Pharmacogenomics Journal·B A ThomaeR M Weinshilboum
Feb 7, 2003·The New England Journal of Medicine·Richard Weinshilboum
Aug 19, 2003·British Journal of Pharmacology·Araba A AdjeiRichard M Weinshilboum
Nov 25, 2003·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·Loretta Theresa Ford, Jonathan David Berg
Jun 23, 2004·British Journal of Clinical Pharmacology·Somrudee SrimartpiromWichittra Tassaneeyakul
Jun 22, 2005·Proceedings of the National Academy of Sciences of the United States of America·Liewei WangRichard M Weinshilboum
Oct 8, 2005·Journal of Computational Chemistry·David Van Der SpoelHerman J C Berendsen
Oct 13, 2005·Pharmacogenetics and Genomics·Oreste E SalavaggioneRichard M Weinshilboum
Jun 28, 2006·The Pharmacogenomics Journal·M A T HildebrandtE D Wieben
Sep 2, 2006·Drug Metabolism and Pharmacokinetics·Wichittra TassaneeyakulWongwiwat Tassaneeyakul
Jul 9, 2008·Clinical Chemistry and Laboratory Medicine : CCLM·Riin TammAndres Metspalu
Aug 19, 2008·Pharmacogenetics and Genomics·Shuta UjiieMasahiro Hiratsuka
Sep 30, 2008·Pharmacogenetics and Genomics·Fang LiRichard M Weinshilboum

❮ Previous
Next ❯

Citations

Feb 15, 2013·Pharmacogenetics and Genomics·Malin L AppellSally A Coulthard
Jul 30, 2010·Biomedical Papers of the Medical Faculty of the University Palacký, Olomouc, Czechoslovakia·Petra JancovaEva Anzenbacherova
Mar 17, 2012·Clinical Therapeutics·Manuel RománFrancisco Abad-Santos
Sep 28, 2015·Computational Biology and Chemistry·Esmat Fazel-NajafabadiMaryam Sedghi
Feb 13, 2013·Journal of Clinical Pharmacology·Lara ColleoniPia Bernasconi
Mar 8, 2018·Clinical Pharmacokinetics·Luc J J DerijksAdriaan A van Bodegraven
Oct 1, 2010·Pharmacogenetics and Genomics·Malin Lindqvist AppellLars-Göran Mårtensson

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autophagy & Model Organisms

Autophagy is a cellular process that allows degradation by the lysosome of cytoplasmic components such as proteins or organelles. Here is the latest research on autophagy & model organisms